Edinburgh Research Explorer

Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?

Research output: Contribution to journalArticle

Standard

Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies? / Kunath, Tilo; Natalwala, Ammar; Chan, Claire; Chen, Yixi; Stecher, Benjamin; Taylor, Martin; Khan, Sadaquate; Muqit, Miratul M K.

In: European Journal of Neuroscience, 26.12.2018.

Research output: Contribution to journalArticle

Harvard

Kunath, T, Natalwala, A, Chan, C, Chen, Y, Stecher, B, Taylor, M, Khan, S & Muqit, MMK 2018, 'Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?', European Journal of Neuroscience. https://doi.org/10.1111/ejn.14314

APA

Kunath, T., Natalwala, A., Chan, C., Chen, Y., Stecher, B., Taylor, M., ... Muqit, M. M. K. (2018). Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies? European Journal of Neuroscience. https://doi.org/10.1111/ejn.14314

Vancouver

Kunath T, Natalwala A, Chan C, Chen Y, Stecher B, Taylor M et al. Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies? European Journal of Neuroscience. 2018 Dec 26. https://doi.org/10.1111/ejn.14314

Author

Kunath, Tilo ; Natalwala, Ammar ; Chan, Claire ; Chen, Yixi ; Stecher, Benjamin ; Taylor, Martin ; Khan, Sadaquate ; Muqit, Miratul M K. / Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?. In: European Journal of Neuroscience. 2018.